Literature DB >> 661964

Amide and i-amino derivatives of F prostaglandins as prostaglandin antagonists.

Y T Maddox, P W Ramwell, C S Shiner, E J Corey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 661964     DOI: 10.1038/273549a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.

Authors:  D F Woodward; A H Krauss; J Chen; D W Gil; K M Kedzie; C E Protzman; L Shi; R Chen; H A Krauss; A Bogardus; H T Dinh; L A Wheeler; S W Andrews; R M Burk; T Gac; M B Roof; M E Garst; L J Kaplan; G Sachs; K L Pierce; J W Regan; R A Ross; M F Chan
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.

Authors:  Najam A Sharif; Peter G Klimko
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

3.  Biasing the prostaglandin F2α receptor responses toward EGFR-dependent transactivation of MAPK.

Authors:  Eugénie Goupil; Veronica Wisehart; Etienne Khoury; Brandon Zimmerman; Sahar Jaffal; Terence E Hébert; Stéphane A Laporte
Journal:  Mol Endocrinol       Date:  2012-05-25

4.  Novel tail and head group prostamide probes.

Authors:  David F Finnegan; Erin L Shelnut; Spyros P Nikas; Nan Chiang; Charles N Serhan; Alexandros Makriyannis
Journal:  Bioorg Med Chem Lett       Date:  2015-02-04       Impact factor: 2.823

Review 5.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

Review 6.  Prostamides (prostaglandin-ethanolamides) and their pharmacology.

Authors:  D F Woodward; Y Liang; A H-P Krauss
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.